La Iniciativa de Medicamentos Innovadores (IMI2) ha añadido y actualizado los topics que saldrán en futuras convocatorias de financiación:

• European Health Data Network (EHDN)
• Analysing the infectious disease burden and the use of vaccines to improve healthy years in aging populations
• Discovery and characterization of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics to treat neurodegenerative & metabolic diseases
• European Screening Centre: unique library for attractive biology (ESCulab) 
• Development and validation of technology enabled, quantitative and sensitive measures of functional decline in people with early stage Alzheimer's disease (RADAR-AD)
• Fairification of IMI and EFPIA data 
• Development of sensitive and validated clinical endpoints in primary Sjögren's syndrome (PSS)
• Exploitation of IMI project results

---

Fuente: IMI